Article and Video CATEGORIES

Cancer Journey

Search By

Access & Assistance for ALK+, ROS1 & EGFR Patients
Author
GRACE Videos and Articles

AR_2015_Bietry_Access_Assistance_ALK_ROS1_EGFR

 

Brendan Bietry of the Patient Advocate Foundation discusses the financial assistance programs available to lung cancer patients who receive targeted therapies.

[powerpress]

[ratingwidget post_id=0]

Please feel free to offer comments and raise questions in our Discussion Forums.

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora

Recent Comments

JOIN THE CONVERSATION
I don't know what to do. No…
By Ascardino on
Hi Hopish hope,  Welcome to…
By JanineT GRACE … on
Thank you for sharing
By LeviDrake on